Tiziana Ottone Selected Research

AR C155858

1/2020

Targeting Lactate Metabolism by Inhibiting MCT1 or MCT4 Impairs Leukemic Cell Proliferation, Induces Two Different Related Death-Pathways and Increases Chemotherapeutic Sensitivity of Acute Myeloid Leukemia Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tiziana Ottone Research Topics

Disease

20	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2009
14	Acute Promyelocytic Leukemia 01/2022 - 10/2008
12	Leukemia 01/2022 - 10/2008
10	Neoplasms (Cancer) 01/2022 - 10/2008
4	Residual Neoplasm 01/2021 - 03/2015
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 01/2019
2	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 09/2021
2	Disease Progression 01/2022 - 01/2022
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 06/2011
2	Pancytopenia 10/2020 - 01/2019
2	Multiple Sclerosis 03/2009 - 10/2008
1	Genomic Instability 01/2022
1	Inflammation (Inflammations) 01/2022
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2022
1	Infections 01/2022
1	Neutropenia 01/2022
1	COVID-19 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2021
1	Disseminated Intravascular Coagulation 01/2021
1	Myeloid Sarcoma (Chloroma) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 10/2020
1	Necrosis 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 02/2009
1	Breast Neoplasms (Breast Cancer) 10/2008
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 05/2007
1	Polycythemia (Erythrocytosis) 05/2007
1	Thrombocytosis (Thrombocythemia) 05/2007

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 09/2021 - 03/2015
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021 - 01/2018
4	NucleophosminIBA 01/2019 - 01/2009
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2009
3	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 01/2019
3	Arsenic Trioxide (Trisenox)FDA Link 01/2021 - 10/2018
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 06/2011
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2022 - 01/2021
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2022 - 01/2021
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 03/2015
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2021
2	ArsenicIBA 01/2021 - 01/2019
2	Biological ProductsIBA 01/2021 - 01/2019
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021 - 02/2009
2	Mutant Proteins (Protein, Mutant)IBA 12/2019 - 09/2010
2	trioctyl phosphine oxide (TOPO)IBA 03/2014 - 03/2009
2	Mitoxantrone (Novantrone)FDA LinkGeneric 03/2009 - 10/2008
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 03/2009 - 10/2008
1	Pharmaceutical PreparationsIBA 01/2022
1	venetoclaxIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	CPX-351IBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	gilteritinibIBA 01/2021
1	Poly Adenosine Diphosphate RiboseIBA 01/2021
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 12/2020
1	A-Form DNA (A-DNA)IBA 12/2020
1	RadiopharmaceuticalsIBA 10/2020
1	Radium-223IBA 10/2020
1	syrosingopineIBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	AR C155858IBA 01/2020
1	PoisonsIBA 01/2019
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	AC-73IBA 01/2019
1	fms-Like Tyrosine Kinase 3IBA 09/2015
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2015
1	olaparibIBA 03/2015
1	Epirubicin (Ellence)FDA LinkGeneric 03/2014
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 03/2014
1	Imatinib Mesylate (Gleevec)FDA Link 06/2011
1	sphingosine kinaseIBA 06/2011
1	Monoclonal AntibodiesIBA 09/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2009
1	polyacrylamideIBA 01/2009
1	Genetic Markers (Genetic Marker)IBA 05/2007

Therapy/Procedure

20	Therapeutics 01/2022 - 10/2008
4	Drug Therapy (Chemotherapy) 10/2020 - 01/2018
3	Aftercare (After-Treatment) 01/2022 - 10/2008
2	Stem Cell Transplantation 01/2019 - 01/2019
1	Injections 10/2020
1	Salvage Therapy 01/2019
1	Precision Medicine 01/2019